Poly(ADP-ribose) polymerase-1 (PARP-1) is a base excision repair (BER) protein that binds to DNA single strand breaks (SSBs) and subsequently synthesizes and transfers poly(ADP-ribose) polymers to various nuclear proteins. Numerous biochemical studies have implicated PARP-1 as a modulator of BER; however, the role of PARP-1 in BER in living cells remains unclear partly due to lack of accurate quantitation of BER intermediates existing in cells. Since DT40 cells, chicken B lymphocytes, naturally lack PARP-2, DT40 cells allow for the investigation of the PARP-1 null phenotype without confounding by PARP-2. To test the hypothesis that PARP-1 is necessary for efficient BER during methylmethane sulfonate (MMS) exposure in vertebrate cells, intact DT40 cells and their isogenic PARP-1 null counterparts were challenged with different exposure scenarios for phenotypic characterization. With chronic exposure, PARP-1 null cells exhibited sensitivity to MMS but with an acute exposure did not accumulate base lesions or AP sites to a greater extent than wild-type cells. However, an increase in SSB content in PARP-1 null cell DNA, as indicated by glyoxal gel electrophoresis under neutral conditions, suggested the presence of BER intermediates. These data suggest that during exposure, PARP-1 impacts the stage of BER after excision of the deoxyribosephosphate moiety from the 5' end of DNA strand breaks by polymerase beta.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784157PMC
http://dx.doi.org/10.1016/j.mrfmmm.2009.09.006DOI Listing

Publication Analysis

Top Keywords

parp-1 null
16
strand breaks
12
dt40 cells
12
cells
10
parp-1
10
dna single
8
single strand
8
ber intermediates
8
exposure parp-1
8
ber
7

Similar Publications

Anticancer effect of AZD2461 PARP inhibitor against colon cancer cells carrying wt or dysfunctional p53.

Exp Cell Res

November 2021

Department of Experimental Medicine, "Sapienza" University of Rome, Italy. Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Italy. Electronic address:

Colon cancer is one of the most common cancers, currently treated with traditional chemotherapies or alternative therapies. However, these treatments are still not enough effective and induce several side effects, so that the search of new therapeutic strategies is needed. The use of Poly-(ADP-ribose)-polymerase (PARP) inhibitors, although originally approved against BRCA-1 or BRCA-2 mutated cancers, has been extended, particularly in combination with other treatments, to cure cancers that do not display defects in DNA repair signaling pathways.

View Article and Find Full Text PDF

Development of renal failure in PargParp-1 null and Timm23 hypomorphic mice.

Biochem Pharmacol

September 2019

Department of Frontier Life Sciences, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan; Division of Cellular Signaling, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; Biochemistry Division, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Electronic address:

Article Synopsis
  • Poly(ADP-ribose) glycohydrolase (Parg) is crucial for breaking down poly(ADP-ribose), and deleting part of its gene in mice results in embryos dying between 4.5 and 9.5 days of development.
  • Introducing a deficiency in poly(ADP-ribose) polymerase-1 (Parp-1) may rescue some of the embryonic lethality, indicating Parp-1's role in the lethality of Parg embryos and highlighting the importance of Parg for embryonic growth.
  • Mice with both Parg and Parp-1 deficiencies show severe kidney issues and early death, suggesting that the combined loss of these proteins can lead
View Article and Find Full Text PDF

DNA Damage-Response Pathway Heterogeneity of Human Lung Cancer A549 and H1299 Cells Determines Sensitivity to 8-Chloro-Adenosine.

Int J Mol Sci

May 2018

Department of Biochemistry and Molecular Biology, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, China.

Article Synopsis
  • H1299 lung cancer cells, lacking p53, are more sensitive to the drug 8-chloro-adenosine (8-Cl-Ado) compared to A549 cells, which have functional p53.
  • The hypersensitivity in H1299 cells is due to an accumulation of DNA double-strand breaks (DSBs), primarily caused by defective DNA repair mechanisms and increased replication stress.
  • Understanding the distinct DNA damage-response pathways in these cancer cells could help develop better chemotherapy strategies tailored to improve patient outcomes.
View Article and Find Full Text PDF

A model has been proposed in which JIL-1 kinase-mediated H3S10 and H2Av phosphorylation is required for transcriptional elongation and heat shock-induced chromatin decondensation. However, here we show that although H3S10 phosphorylation is indeed compromised in the null mutant, chromatin decondensation at heat shock loci is unaffected in the absence of JIL-1 as well as of H2Av and that there is no discernable decrease in the elongating form of RNA polymerase II in either mutant. Furthermore, mRNA for the major heat shock protein Hsp70 is transcribed at robust levels in both and null mutants.

View Article and Find Full Text PDF

Heme oxygenase-1-mediated apoptosis under cadmium-induced oxidative stress is regulated by autophagy, which is sensitized by tumor suppressor p53.

Biochem Biophys Res Commun

October 2016

Department of Premedics, School of Medicine, Chosun University, Gwangju 501-759, South Korea. Electronic address:

Heme oxygenase-1 (HO-1) is a stress-inducible cytoprotective enzyme. It is often overexpressed in different types of cancers and promotes cell survival. However, the role of HO-1 and the underlying molecular mechanism of cadmium (Cd)-induced oxidative stress in cancer cells remain undefined.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!